GLP-1R/CRE Luciferase Reporter HEK293 Cell Line
GLP-1R/CRE Luciferase Reporter HEK293 Cell Line is an engineered HEK293 cell line expressing firefly luciferase under the control of cAMP response element (CRE), and human GLP-1R (Glucagon-like peptide 1 receptor; accession number BC113493). Activation of GLP-1R in these cells can be monitored by measuring luciferase activity.
The functionality of GLP-1R/CRE Luciferase Reporter HEK293 Cell Line was validated in dose-response assays using the peptide agonists Glucagon-like peptide 1 (7-37), Exendin-4, Lixisenatide, GLP-1 moiety from dulaglutide, Semaglutide, Tirzepatide and Retatrutide. This cell line has also been validated in a dose-response assay using a small molecule agonist, Danuglipron. GLP-1R/CRE Luciferase Reporter HEK293 Cell Line responds to agonists by inducing luciferase activity in a dose-dependent manner.
Figure 1. Illustration of mechanism of action in the GLP-1R/CRE Luciferase Reporter HEK293 Cell Line.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
更多详情：http://www.bpsbioscience.com.cn/Products-37982132.html
https://www.chem17.com/st542058/product_37982132.html
原文链接：http://www.dylian.net/news/13608.html，转载和复制请保留此链接。
以上就是关于GLP-1R/CRE Luciferase Reporter全部的内容，关注我们，带您了解更多相关内容。
以上就是关于GLP-1R/CRE Luciferase Reporter全部的内容，关注我们，带您了解更多相关内容。
特别提示：本信息由相关用户自行提供，真实性未证实，仅供参考。请谨慎采用，风险自负。
